本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Inhibrx Biosciences

105.61
-4.8600-4.40%
盤後105.610.00000.00%16:44 EDT
成交量:25.16萬
成交額:2,664.59萬
市值:15.49億
市盈率:-11.90
高:109.44
開:109.44
低:104.85
收:110.47
52周最高:155.29
52周最低:26.19
股本:1,467.12萬
流通股本:863.89萬
量比:0.40
換手率:2.91%
股息:- -
股息率:- -
每股收益(TTM):-8.8768
每股收益(LYR):-9.0434
淨資產收益率:-1773.60%
總資產收益率:-43.61%
市淨率:-29.25
市盈率(LYR):-11.68

資料載入中...

2024/03/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/28

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/23

重要事件披露

Form 8-K - Current report
2023/11/10

重要事件披露

Form 8-K - Current report
2023/11/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/02

重要事件披露

Form 8-K - Current report
2023/09/20

重要事件披露

Form 8-K - Current report
2023/08/29

重要事件披露

Form 8-K - Current report
2023/08/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/07

重要事件披露

Form 8-K - Current report
2023/05/30

重要事件披露

Form 8-K - Current report
2023/05/25

重要事件披露

Form 8-K - Current report